AYUSH ministry to set up expert group to examine use of Ashwagandha leaves in ASU drugs
PTI, Nov 25, 2021, 7:37 PM IST
The Ministry of AYUSH has decided to re-examine the matter relating to the use of Ashwagandha leaves in Ayurveda, Siddha and Unani drugs by constituting an expert group in this regard.
The ministry had earlier issued an advisory against the use of such leaves in Ayurveda, Siddha and Unani (ASU) drugs.
In the wake of the ministry barring the use of Ashwagandha leaves (via letter dated October 6 to the ASU Drugs Manufacturing Association), representations had been received from ASU Drugs Manufacturing Industry partners, a statement by the ministry said.
The AYUSH ministry had also invited the stakeholders to discuss their concerns about the utilisation of Ashwagandha leaves in ASU products.
“Based on this discussion, the ministry has decided to re-examine the advisory issued to the drug manufacturers to refrain from using Ashwagandha (Withania somnifera) leaves by setting up an expert group,” the statement said.
The expert group will make appropriate recommendations to the Government of India on the use of Ashwagandha leaves/Panchanga of Ashwagandha in ASU products based on scientific evidence, it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Blocked 18 OTT platforms for publishing obscene, vulgar content: Govt
Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam
Rajasthan govt to replace Urdu terms in policing with Hindi words
Congress twisted facts, distorted my statement on Ambedkar: Amit Shah
One dead, 66 rescued after ferry capsizes off Mumbai coast
MUST WATCH
Latest Additions
Assembly clears Mysuru Development Authority Bill
Blocked 18 OTT platforms for publishing obscene, vulgar content: Govt
Boy critically injured after tree branch falls on him in Bengaluru
Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam
Four dead in road accident in Kolar
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.